The United States of America, as represented by The Secretary, Department of Health and Human Services;Laboratoire HRA Pharma
发明人:
ULMANN, Andre,GAINER, Erin,BLITHE, Diana,NIEMAN, Lynette,MATHE, Henri Camille
申请号：
HUE10717084
公开号：
HUE029434T2
申请日:
2010.04.13
申请国别(地区):
HU
年份:
2017
代理人:
摘要：
The invention relates to a method for on-demand contraception, which method comprises administering a progestogen agent or progesterone receptor modulator, such as 17a-acetoxy-llb-[4-N, N-dimethylamino-phenyl)-19-norpregna- 4, 9-diene-3, 20-dione (ulipristal acetate) in a woman, within 72 hours before an intercourse or within 120 hours after the intercourse.
